FindTrial
Sign In

ZO-Y60 Phase III clinical trial

ZO-Y60 Phase III clinical trial

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080221685
Enrollment
Unknown
Registered
2012-01-10
Start date
2012-01-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal disease

Interventions

investigational material(s) Generic name etc : ZO-Y60 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investiga

Sponsors

ZERIA Pharmaceutical Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with gasstrointestinal disease. Out-patients who signed a written informed consent. If patient age is under 20 years old, a written informed consent have to be obtained from both participant and his/her parent(s).

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026